Lupin has informed that it enclosed a Press Release titled ‘Lupin and TB Alliance Join Forces to Advance Telacebec for the Treatment of Tuberculosis and Other Mycobacterial Diseases.’
The above information is a part of company’s filings submitted to BSE.